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Abstract
In spite of the progress in material engineering and ventricular assist devices construction, thromboembolism remains the most
crucial problem in mechanical heart supporting systems. Therefore, the ability to monitor the patient’s blood for clot formation
should be considered an important factor in development of heart supporting systems. The well-known methods for automatic
embolus detection are based on the monitoring of the ultrasound Doppler signal. A working system utilizing ultrasound Doppler
is being developed for the purpose of ﬂow estimation and emboli detection in the clinical artiﬁcial heart ReligaHeart EXT. The
system will be based on the existing dual channel multi-gate Doppler device with RF digital processing. A specially developed
clamp-on cannula probe, equipped with 2 − 4MHz piezoceramic transducers, enables easy system setup. We present the issues
related to the development of automatic emboli detection via Doppler measurements. We consider several algorithms for the ﬂow
estimation and emboli detection. We discuss their eﬃciency and confront them with the requirements of our experimental setup.
Theoretical considerations are then met with preliminary experimental ﬁndings from a) ﬂow studies with blood mimicking ﬂuid
and b) in-vitro ﬂow studies with animal blood. Finally, we discuss some more methodological issues - we consider several possible
approaches to the problem of veriﬁcation of the accuracy of the detection system.
c© 2015 The Authors. Published by Elsevier B.V.
Peer-review under responsibility of the Scientiﬁc Committee of 2015 ICU Metz.
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1. Introduction
The ReligaHeart EXT is an extracorporeal, pneumatic ventricular assist device (VAD) that is a part of a Cardiac
Assist System currently developed in the Foundation of Cardiac Surgery Development, Poland. The system utilize
results from the existing extracorporeal heart supporting system POLCAS, which was applied in more than 300 cases,
mostly in Poland. ReligaHeart EXT VAD has been successfully tested during in-vitro investigations on blood as well
as in animal trials and it is ready for the second stage of clinical trials.
One of the most important issues in VADs is thromboembolism. Blood pumps may activate the coagulation system
in several ways, e.g. blood contact with artiﬁcial material (biocompatible polymer or titanium covered by biocom-
patible layers), excessive shear stress, intermittent cavitation, excessive speed of pressure changes, blood stagnation
or turbulent ﬂow. To avoid these complications, the coagulation system should be partially blocked by pharmacolog-
ical treatment. But the higher the blocking of coagulation system, the higher the risk of bleeding, especially bowels
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bleeding or intracerebral hemorrhage, leading even to death. Routinely monitored blood coagulological parameters
(e.g. INR, ApTT) give information only about the degree of coagulation system blocking but not about its ability to
counteract clots forming. Therefore, a better way to adjust the anticoagulant medication seems to be observing the
eﬀect of anticoagulation. Thus it was proposed to monitor the VAD via an automatic microemboli detection system
based on the principles of Doppler ultrasound.
2. Detection system
The backscattering of the ultrasound wave on a suﬃciently large particle moving in the vessel is observable in a
form of characteristic Doppler signals, known as high-intensity triansient signals (HITS). An aalysis of these changes
may provide partial information about the physical properties of the particle. One could distinguish four problems
here: (a) detection of HITS; (b) classiﬁcation of HITS into two groups: data containing microembolic signal and
data free from microembolic signal (noise and artifact changes); (c) distinction between signals from gaseous and
solid microemboli; (d) estimation of the solid microemboli size. We assume that in our target experimental situations
only solid emboli are present. Other advantages over other clinical Doppler measurement situations are the constant
diameter of the cannula and the ﬁxed position of the probe.
Fig. 1. An example of HITS.
2.1. Doppler system
The ultrasonic probe is to be connected to the extracorporeal plastic tubing. During preliminary studies it was
observed that the rounded shape of the tubing caused a lensing of the ultrasound wave and in eﬀect, a reduction of the
eﬀective sample volume. Therefore, a special clamp-on probe was designed to ﬂatten the tubing. Two tranducerds
(2 and 4MHz respectively) were used - potentially allowing for the implementation of emboli sizing algorithms. The
Doppler I/Q data aquisition is performed using the digiTDS - a multigate Doppler ultrasound system developed in the
Institute of Fundamental Technological Research of Polish Academy of Sciences.
3. Validation
It is generally assumed that HITS are audible as a characteristic sound when audio representation of the Doppler
data is considered. Thus a subjective analysis of audio Doppler data by a human expert was established as a gold stan-
dard for diagnosis of the thromboembolism in various clinical applications. For this reason, the automatic detection
systems are usually validated via comparison with human expert ﬁndings. However, this approach is ﬂawed. Firstly,
it is not clear what the limits of the human perception in this matter are, i.e. what part of HITS present in the whole
signal are detectable by a human expert. Secondly, such validation gives no information about the general sensitivity
of the given Doppler system - i.e. what kind of emboli are detectable in the signal as HITS.
Thus a more objective method of validation should be sought. In our studies we consider an in-vitro method of vali-
dation via optical measurement. The aim of the validation was to establish a minimal size of the particle measurable
in our Doppler ultrasound system. The experiments were performed on a calibrated ﬂow phantom supplied with the
same type of tubing as the one used in the target VAD (E-3603 ﬂexible plastic tubing, Tygon, France). A commercially
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available blood mimicking ﬂuid Model 046 was used (CIRS, Norfolk, Virginia, USA) to acquire a realistic Doppler
data.
The main idea was to collect optical images from a high-speed camera placed near the ultrasonic probe in a way that
ensured that a moving particle will pass in a short time through both the camera and the Doppler sample volumes - thus
allowing for a comparison of both types of data collected. Two methods for optical measurement combined with two
types of calibrated particles were considered: a) measuring the laser light scattered on the particles moving through
the sample volume and b) using the ﬂuorescent particles and measurement of the light emitted by the particles. The
ﬁrst approach was ineﬀective due to high scattering of the light on the particles constituting the blood mimicking ﬂuid.
The second method involved using ﬂuorescent particles emitting light which wavelength was signiﬁcantly diﬀerent
from the wavelength of the laser light that was triggering the ﬂuorescence. Therefore, it was possible to separate
the useful signal from the background with use of an optical ﬁlter of matched bandwidth. Consequently, the second
method was chosen for further measurements.
Calibrated green ﬂuorescent microspheres (Microgenics Corporation, Fremont, California, USA) were used. One
hundred images per second were collected via a high-speed camera. An averaged brightness of the images could be
used as a parameter for detection of the activated ﬂuorescent particle. However, in a cloudy medium such as the used
blood mimicking ﬂuid the changes in the average brightness were hardly distinguishable from noise. A sum of the
pixels that were brightened at least by a certain factor appeared to be much more speciﬁc indicator of the activated
ﬂuorescence.
Additionally, two preliminary studies were performed on a percine blood circulating in a system connected to the
target VAD. The possibility of applying an optical method in such study is limited. However, the study of embolic
material formed during the experiment provided an additional insight into the subject.
3.1. HITS detection
Three methods based on diﬀerent estimators were tested on the data collected. In every method the detection
procedure consists of comparing the instantaneous value of the estimator to the threshold (ﬁxed or adaptive).
An embolus causes an increase in the signal energy [? ]. Thus, the simplest estimator under consideration is the
absolute value of the Doppler I/Q signal ﬁltered with a moving average ﬁlter.
The second estimator, reported in [? ], is based on the assumption that the ﬁltered blood signal may be modelled
as a stationary signal, while the embolic signals are non-stationary. The autoregressive models (AR) are ﬁtted to the
fragments of signal and two values may be used as the estimator - the model prediction error or the AR coeﬃcients.
The ﬁrst coeﬃcient of the AR model seems to be a more stable estimator than the prediction error.
The third approach was proposed in [? ] using the instantaneous frequency estimator. It is assumed that HITS are
narrow band signals (in relation to wide frequency band of the blood signal with no emboli present) and that this
diﬀerence in frequency bandwidth should be observable as a change in the deviation of the instantaneous frequency
estimator.
4. Discussion
All estimators tested are sensitive to embolic changes in the Doppler signal as seen on Fig 2. Data sets consisting
of 25 seconds of measurements were collected and analysed. Manual ﬁtting of the detection thresholds allowed even
for 100% sensivity as compared to the optical ﬁndings - however these thresholds were not consistent among diﬀerent
data sets.
A manual analysis of Doppler data revealed up to 110% more HITS per data set as compared to the optical ﬁndings.
It was observed that the blood mimicking ﬂuid particles spontaneously formed conglomerates that apparently were
detectable as emboli. Consequently, the exact mapping of optical data to the Doppler signal was not possible.
The most problematic aspect of the validation is the issue of emboli shapes. In the in-vitro study spherical particles
were used (e.g. Fig. 3). Similarly, the popular model describing the energy increase in embolic signal - the emboli-
to-blood ratio (EBR), introduced in [? ] - is based on the assumption that the emboli are spherical. However, the
examination of clot samples collected from the porcine blood experiment shows that the real emboli tend to manifest
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Fig. 2. (a) Doppler data; (b) absolute values of Doppler signal with moving average ﬁlter; (c) AR coeﬃcients; (d) instantaneous frequency with
moving average ﬁlter.
Fig. 3. (a) 140μm ﬂuorescent particles; (b) blood clot collected during in vitro study.
in various shapes that are unlikely to cause the same ultrasound backscattering as a spherical particle of the same
volume. A plausible evaluation of any automatic detection system will not be possible without further studies into the
subject of uncertainty resulting from the shapes of emboli.
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